A Randomized, Three-Arm, Dose-Blinded, Parallel-Group Study to Determine the Effect of Avonex Dose Titration on the Severity and Incidence of Interferon Beta-1a-Related Flu Like Symptoms in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors Biogen
- 22 Oct 2011 Results presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
- 13 Sep 2011 Patient numbers changed from 120 to 234 as reported in the abstract
- 13 Sep 2011 Results presented at the 15th Congress of the European Federation of Neurological Societies.